Cannabinoids and the expanded endocannabinoid system in neurological disorders
L Cristino, T Bisogno, V Di Marzo - Nature Reviews Neurology, 2020 - nature.com
Anecdotal evidence that cannabis preparations have medical benefits together with the
discovery of the psychotropic plant cannabinoid Δ9-tetrahydrocannabinol (THC) initiated …
discovery of the psychotropic plant cannabinoid Δ9-tetrahydrocannabinol (THC) initiated …
From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology
A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
FA Iannotti, V Di Marzo, S Petrosino - Progress in lipid research, 2016 - Elsevier
The endocannabinoid system (ECS) is composed of two G protein-coupled receptors
(GPCRs), the cannabinoid CB1 and CB2 receptors, and the two main endogenous lipid …
(GPCRs), the cannabinoid CB1 and CB2 receptors, and the two main endogenous lipid …
Cannabinoid receptors in the central nervous system: their signaling and roles in disease
DA Kendall, GA Yudowski - Frontiers in cellular neuroscience, 2017 - frontiersin.org
The identification and cloning of the two major cannabinoid (CB1 and CB2) receptors
together with the discovery of their endogenous ligands in the late 80s and early 90s …
together with the discovery of their endogenous ligands in the late 80s and early 90s …
Endocannabinoid signalling and the deteriorating brain
V Di Marzo, N Stella, A Zimmer - Nature Reviews Neuroscience, 2015 - nature.com
Ageing is characterized by the progressive impairment of physiological functions and
increased risk of developing debilitating disorders, including chronic inflammation and …
increased risk of developing debilitating disorders, including chronic inflammation and …
Cannabinoid receptors: An update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory …
The identification of the human cannabinoid receptors and their roles in health and disease,
has been one of the most significant biochemical and pharmacological advancements to …
has been one of the most significant biochemical and pharmacological advancements to …
Endocannabinoid system in neurodegenerative disorders
BS Basavarajappa, M Shivakumar… - Journal of …, 2017 - Wiley Online Library
Most neurodegenerative disorders (NDD s) are characterized by cognitive impairment and
other neurological defects. The definite cause of and pathways underlying the progression …
other neurological defects. The definite cause of and pathways underlying the progression …
Alzheimer's disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
The synapse has consistently been considered a vulnerable and critical target within
Alzheimer's disease, and synapse loss is, to date, one of the main biological correlates of …
Alzheimer's disease, and synapse loss is, to date, one of the main biological correlates of …
Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target
As a consequence of an increasingly aging population, the number of people affected by
neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and …
neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and …
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic
E Aso, I Ferrer - Frontiers in pharmacology, 2014 - frontiersin.org
The limited effectiveness of current therapies against Alzheimer's disease (AD) highlights
the need for intensifying research efforts devoted to developing new agents for preventing or …
the need for intensifying research efforts devoted to developing new agents for preventing or …